Skip to main content
DONG-A ST CO.,LTD logo

DONG-A ST CO.,LTD — Investor Relations & Filings

Ticker · 170900 ISIN · KR7170900005 KO Manufacturing
Open in API
Filings indexed 634 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 170900

About DONG-A ST CO.,LTD

https://www.donga-st.com

Dong-A ST CO., LTD. is a pharmaceutical company focused on the research, development, manufacturing, and marketing of ethical drugs, medical devices, and diagnostics. The company's portfolio includes proprietary new drugs such as Stillen (gastritis), Zydena (erectile dysfunction), and Motilitone (functional dyspepsia). Operating from cGMP-compliant facilities, it exports a diverse range of products, including novel drugs, generics, and biopharmaceuticals, to global markets. The company maintains a strong commitment to innovative R&D, with a pipeline featuring first-in-class therapeutic candidates for metabolic diseases, including MASH (Metabolic dysfunction-associated steatohepatitis) and obesity, which are being advanced through a dedicated global R&D base.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document begins with the Korean title "분기보고서" (Quarterly Report) covering the period 2026-01-01 to 2026-03-31 (1st quarter of the 14th fiscal year). It is filed with the Financial Services Commission and Korea Exchange, contains detailed consolidated financial statements, segment sales data, production statistics, risk management discussion, and other substantive financial disclosures. This meets the definition of a comprehensive interim/quarterly report (not merely an earnings release or announcement). Therefore, it is classified as an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
기업설명회(IR)개최(안내공시)
Investor Presentation Classification · 78% confidence The document is a public announcement (안내공시) scheduling an upcoming기업설명회(IR) — i.e. an investor presentation/event — detailing date, venue, participants, agenda, and where IR materials will be posted. It is not the full presentation slides or transcript itself, but it clearly falls under the IR meeting/presentation category rather than an earnings release or regulatory filing. Therefore, it is classified as an Investor Presentation (IP).
2026-04-27 Korean
영업(잠정)실적(공정공시)
Earnings Release Classification · 90% confidence The document is a short press release of preliminary (잠정) quarterly business results for Q1 2026, showing key financial figures (revenue, operating profit, net income) compared to prior periods. It is an initial announcement of periodical financial results rather than a full interim report. This matches the definition of an Earnings Release (ER). Q1 2026
2026-04-27 Korean
결산실적공시예고(안내공시)
Report Publication Announcement Classification · 85% confidence The document is a brief notice announcing the upcoming publication date (2026-04-27) of the company’s financial results for the quarter ending March 31, 2026. It does not contain the actual financial data but simply schedules the release. This meets the criteria for a Report Publication Announcement (RPA).
2026-04-23 Korean
기업설명회(IR)개최(안내공시)
Investor Presentation Classification · 80% confidence The document is an announcement of an upcoming investor relations meeting (“기업설명회(IR) 개최(안내공시)”), specifying date, time, participants, format and where IR materials will be posted. Although it does not contain the slides themselves, it clearly relates to an Investor Presentation (IR) event notice. The closest match in our taxonomy is “Investor Presentation (Code: IP).”
2026-04-23 Korean
투자판단관련주요경영사항
Regulatory Filings Classification · 62% confidence The document is a Korean regulatory disclosure titled “투자판단 관련 주요경영사항” announcing a material event (drug approval application to the MFDS). It is not a full financial report (10-K/IR), earnings release, board/management change, capital transaction, or other specific category. It fits the fallback category for miscellaneous regulatory announcements, hence classified as Regulatory Filings (RNS).
2026-04-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.